Saracatinib difumarate
| CAS No. | 893428-72-3 | Cat. No. | BCP25711 |
| Name | Saracatinib difumarate | ||
| Synonyms | AZD0530 difumarate;AZD-0530 difumarate;AZD 0530 difumarate; | ||
| Formula | C35H40ClN5O13 | M. Wt | 774.18 |
| Description | Saracatinib Difumarate is the difumarate salt of saracatinib, an orally available 5-, 7-substituted anilinoquinazoline with anti-invasive and anti-tumor activities. Saracatinib is a dual-specific inhibitor of Src and Abl, protein tyrosine kinases that are overexpressed in chronic myeloid leukemia cells. This agent binds to and inhibits these tyrosine kinases and affects cell motility, cell migration, adhesion, invasion, proliferation, differentiation, and survival. Specifically, Saracatinib inhibits Src kinase-mediated osteoclast bone resorption. | ||
| Related Products | 379231-04-6（Saracatinib） | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase | ||
| Targets | Src/Bcr Abl | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.